Franklin Resources Inc Celldex Therapeutics, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$30.29 - $38.28 $696,760 - $880,554	23,003 New	23,003 $780,000
Q1 2022 May 13, 2022	SELL	$27.64 - $39.32 $146,519 - $208,435	-5,301 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$35.68 - $56.27 $4,602 - $7,258	129 Added 2.49%	5,301 $205,000
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $149,729 - $289,580	5,172 New	5,172 $279,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.